 | • レポートコード：MRC2312MG07763 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、79ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の放射線緊急治療薬市場規模と予測を収録しています。・世界の放射線緊急治療薬市場：売上、2018年-2023年、2024年-2029年 ・世界の放射線緊急治療薬市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の放射線緊急治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ヨウ化カリウム（KI）」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 放射線緊急治療薬のグローバル主要企業は、Amgen、 Anbex、 BTG International、 Cellphire、 Chrysalis BioTherapeutics、 Darnitsa、 Enzychem Lifesciences、 Humanetics、 Mission Pharmacal、 Partner Therapeutics、 Myelo Therapeutics、 Pluriなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、放射線緊急治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の放射線緊急治療薬市場：タイプ別、2018年-2023年、2024年-2029年 世界の放射線緊急治療薬市場：タイプ別市場シェア、2022年 ・ヨウ化カリウム（KI）、プルシアンブルー、DTPA（ジエチレントリアミン五酢酸）、その他 世界の放射線緊急治療薬市場：用途別、2018年-2023年、2024年-2029年 世界の放射線緊急治療薬市場：用途別市場シェア、2022年 ・急性放射線症候群（ARS）、がん治療、放射線被曝、その他 世界の放射線緊急治療薬市場：地域・国別、2018年-2023年、2024年-2029年 世界の放射線緊急治療薬市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における放射線緊急治療薬のグローバル売上、2018年-2023年 ・主要企業における放射線緊急治療薬のグローバル売上シェア、2022年 ・主要企業における放射線緊急治療薬のグローバル販売量、2018年-2023年 ・主要企業における放射線緊急治療薬のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Amgen、 Anbex、 BTG International、 Cellphire、 Chrysalis BioTherapeutics、 Darnitsa、 Enzychem Lifesciences、 Humanetics、 Mission Pharmacal、 Partner Therapeutics、 Myelo Therapeutics、 Pluri ************************************************************* ・調査・分析レポートの概要 放射線緊急治療薬市場の定義 市場セグメント 世界の放射線緊急治療薬市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の放射線緊急治療薬市場規模 世界の放射線緊急治療薬市場規模：2022年 VS 2029年 世界の放射線緊急治療薬市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの放射線緊急治療薬の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の放射線緊急治療薬製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：ヨウ化カリウム（KI）、プルシアンブルー、DTPA（ジエチレントリアミン五酢酸）、その他 放射線緊急治療薬のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：急性放射線症候群（ARS）、がん治療、放射線被曝、その他 放射線緊急治療薬の用途別グローバル売上・予測 ・地域別市場分析 地域別放射線緊急治療薬市場規模 2022年と2029年 地域別放射線緊急治療薬売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Amgen、 Anbex、 BTG International、 Cellphire、 Chrysalis BioTherapeutics、 Darnitsa、 Enzychem Lifesciences、 Humanetics、 Mission Pharmacal、 Partner Therapeutics、 Myelo Therapeutics、 Pluri ... |
This research report provides a comprehensive analysis of the Radiation Emergency Medications market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Radiation Emergency Medications market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Radiation Emergency Medications, challenges faced by the industry, and potential opportunities for market players.
The global Radiation Emergency Medications market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Radiation Emergency Medications market presents opportunities for various stakeholders, including Acute Radiation Syndrome(ARS), Cancer Treatment. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Radiation Emergency Medications market. Additionally, the growing consumer demand present avenues for market expansion.
The global Radiation Emergency Medications market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period.
Key Features:
The research report on the Radiation Emergency Medications market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Radiation Emergency Medications market.
Market Overview: The report provides a comprehensive overview of the Radiation Emergency Medications market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Potassium lodide (KI), Prussian Blue), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Radiation Emergency Medications market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Radiation Emergency Medications market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Radiation Emergency Medications market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Radiation Emergency Medications market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Radiation Emergency Medications market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Radiation Emergency Medications market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Radiation Emergency Medications, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Radiation Emergency Medications market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Radiation Emergency Medications market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Potassium lodide (KI)
Prussian Blue
DTPA (Diethylenetriamine Pentaacetate)
Others
Market segment by Application
Acute Radiation Syndrome(ARS)
Cancer Treatment
Radiation Exposure
Others
Global Radiation Emergency Medications Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Amgen
Anbex
BTG International
Cellphire
Chrysalis BioTherapeutics
Darnitsa
Enzychem Lifesciences
Humanetics
Mission Pharmacal
Partner Therapeutics
Myelo Therapeutics
Pluri
Outline of Major Chapters:
Chapter 1: Introduces the definition of Radiation Emergency Medications, market overview.
Chapter 2: Global Radiation Emergency Medications market size in revenue and volume.
Chapter 3: Detailed analysis of Radiation Emergency Medications manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Radiation Emergency Medications in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Radiation Emergency Medications capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Radiation Emergency Medications Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Radiation Emergency Medications Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Radiation Emergency Medications Overall Market Size
2.1 Global Radiation Emergency Medications Market Size: 2022 VS 2029
2.2 Global Radiation Emergency Medications Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Radiation Emergency Medications Sales: 2018-2029
3 Company Landscape
3.1 Top Radiation Emergency Medications Players in Global Market
3.2 Top Global Radiation Emergency Medications Companies Ranked by Revenue
3.3 Global Radiation Emergency Medications Revenue by Companies
3.4 Global Radiation Emergency Medications Sales by Companies
3.5 Global Radiation Emergency Medications Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Radiation Emergency Medications Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Radiation Emergency Medications Product Type
3.8 Tier 1, Tier 2 and Tier 3 Radiation Emergency Medications Players in Global Market
3.8.1 List of Global Tier 1 Radiation Emergency Medications Companies
3.8.2 List of Global Tier 2 and Tier 3 Radiation Emergency Medications Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Radiation Emergency Medications Market Size Markets, 2022 & 2029
4.1.2 Potassium lodide (KI)
4.1.3 Prussian Blue
4.1.4 DTPA (Diethylenetriamine Pentaacetate)
4.1.5 Others
4.2 By Type – Global Radiation Emergency Medications Revenue & Forecasts
4.2.1 By Type – Global Radiation Emergency Medications Revenue, 2018-2023
4.2.2 By Type – Global Radiation Emergency Medications Revenue, 2024-2029
4.2.3 By Type – Global Radiation Emergency Medications Revenue Market Share, 2018-2029
4.3 By Type – Global Radiation Emergency Medications Sales & Forecasts
4.3.1 By Type – Global Radiation Emergency Medications Sales, 2018-2023
4.3.2 By Type – Global Radiation Emergency Medications Sales, 2024-2029
4.3.3 By Type – Global Radiation Emergency Medications Sales Market Share, 2018-2029
4.4 By Type – Global Radiation Emergency Medications Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Radiation Emergency Medications Market Size, 2022 & 2029
5.1.2 Acute Radiation Syndrome(ARS)
5.1.3 Cancer Treatment
5.1.4 Radiation Exposure
5.1.5 Others
5.2 By Application – Global Radiation Emergency Medications Revenue & Forecasts
5.2.1 By Application – Global Radiation Emergency Medications Revenue, 2018-2023
5.2.2 By Application – Global Radiation Emergency Medications Revenue, 2024-2029
5.2.3 By Application – Global Radiation Emergency Medications Revenue Market Share, 2018-2029
5.3 By Application – Global Radiation Emergency Medications Sales & Forecasts
5.3.1 By Application – Global Radiation Emergency Medications Sales, 2018-2023
5.3.2 By Application – Global Radiation Emergency Medications Sales, 2024-2029
5.3.3 By Application – Global Radiation Emergency Medications Sales Market Share, 2018-2029
5.4 By Application – Global Radiation Emergency Medications Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Radiation Emergency Medications Market Size, 2022 & 2029
6.2 By Region – Global Radiation Emergency Medications Revenue & Forecasts
6.2.1 By Region – Global Radiation Emergency Medications Revenue, 2018-2023
6.2.2 By Region – Global Radiation Emergency Medications Revenue, 2024-2029
6.2.3 By Region – Global Radiation Emergency Medications Revenue Market Share, 2018-2029
6.3 By Region – Global Radiation Emergency Medications Sales & Forecasts
6.3.1 By Region – Global Radiation Emergency Medications Sales, 2018-2023
6.3.2 By Region – Global Radiation Emergency Medications Sales, 2024-2029
6.3.3 By Region – Global Radiation Emergency Medications Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Radiation Emergency Medications Revenue, 2018-2029
6.4.2 By Country – North America Radiation Emergency Medications Sales, 2018-2029
6.4.3 US Radiation Emergency Medications Market Size, 2018-2029
6.4.4 Canada Radiation Emergency Medications Market Size, 2018-2029
6.4.5 Mexico Radiation Emergency Medications Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Radiation Emergency Medications Revenue, 2018-2029
6.5.2 By Country – Europe Radiation Emergency Medications Sales, 2018-2029
6.5.3 Germany Radiation Emergency Medications Market Size, 2018-2029
6.5.4 France Radiation Emergency Medications Market Size, 2018-2029
6.5.5 U.K. Radiation Emergency Medications Market Size, 2018-2029
6.5.6 Italy Radiation Emergency Medications Market Size, 2018-2029
6.5.7 Russia Radiation Emergency Medications Market Size, 2018-2029
6.5.8 Nordic Countries Radiation Emergency Medications Market Size, 2018-2029
6.5.9 Benelux Radiation Emergency Medications Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Radiation Emergency Medications Revenue, 2018-2029
6.6.2 By Region – Asia Radiation Emergency Medications Sales, 2018-2029
6.6.3 China Radiation Emergency Medications Market Size, 2018-2029
6.6.4 Japan Radiation Emergency Medications Market Size, 2018-2029
6.6.5 South Korea Radiation Emergency Medications Market Size, 2018-2029
6.6.6 Southeast Asia Radiation Emergency Medications Market Size, 2018-2029
6.6.7 India Radiation Emergency Medications Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Radiation Emergency Medications Revenue, 2018-2029
6.7.2 By Country – South America Radiation Emergency Medications Sales, 2018-2029
6.7.3 Brazil Radiation Emergency Medications Market Size, 2018-2029
6.7.4 Argentina Radiation Emergency Medications Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Radiation Emergency Medications Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Radiation Emergency Medications Sales, 2018-2029
6.8.3 Turkey Radiation Emergency Medications Market Size, 2018-2029
6.8.4 Israel Radiation Emergency Medications Market Size, 2018-2029
6.8.5 Saudi Arabia Radiation Emergency Medications Market Size, 2018-2029
6.8.6 UAE Radiation Emergency Medications Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Amgen
7.1.1 Amgen Company Summary
7.1.2 Amgen Business Overview
7.1.3 Amgen Radiation Emergency Medications Major Product Offerings
7.1.4 Amgen Radiation Emergency Medications Sales and Revenue in Global (2018-2023)
7.1.5 Amgen Key News & Latest Developments
7.2 Anbex
7.2.1 Anbex Company Summary
7.2.2 Anbex Business Overview
7.2.3 Anbex Radiation Emergency Medications Major Product Offerings
7.2.4 Anbex Radiation Emergency Medications Sales and Revenue in Global (2018-2023)
7.2.5 Anbex Key News & Latest Developments
7.3 BTG International
7.3.1 BTG International Company Summary
7.3.2 BTG International Business Overview
7.3.3 BTG International Radiation Emergency Medications Major Product Offerings
7.3.4 BTG International Radiation Emergency Medications Sales and Revenue in Global (2018-2023)
7.3.5 BTG International Key News & Latest Developments
7.4 Cellphire
7.4.1 Cellphire Company Summary
7.4.2 Cellphire Business Overview
7.4.3 Cellphire Radiation Emergency Medications Major Product Offerings
7.4.4 Cellphire Radiation Emergency Medications Sales and Revenue in Global (2018-2023)
7.4.5 Cellphire Key News & Latest Developments
7.5 Chrysalis BioTherapeutics
7.5.1 Chrysalis BioTherapeutics Company Summary
7.5.2 Chrysalis BioTherapeutics Business Overview
7.5.3 Chrysalis BioTherapeutics Radiation Emergency Medications Major Product Offerings
7.5.4 Chrysalis BioTherapeutics Radiation Emergency Medications Sales and Revenue in Global (2018-2023)
7.5.5 Chrysalis BioTherapeutics Key News & Latest Developments
7.6 Darnitsa
7.6.1 Darnitsa Company Summary
7.6.2 Darnitsa Business Overview
7.6.3 Darnitsa Radiation Emergency Medications Major Product Offerings
7.6.4 Darnitsa Radiation Emergency Medications Sales and Revenue in Global (2018-2023)
7.6.5 Darnitsa Key News & Latest Developments
7.7 Enzychem Lifesciences
7.7.1 Enzychem Lifesciences Company Summary
7.7.2 Enzychem Lifesciences Business Overview
7.7.3 Enzychem Lifesciences Radiation Emergency Medications Major Product Offerings
7.7.4 Enzychem Lifesciences Radiation Emergency Medications Sales and Revenue in Global (2018-2023)
7.7.5 Enzychem Lifesciences Key News & Latest Developments
7.8 Humanetics
7.8.1 Humanetics Company Summary
7.8.2 Humanetics Business Overview
7.8.3 Humanetics Radiation Emergency Medications Major Product Offerings
7.8.4 Humanetics Radiation Emergency Medications Sales and Revenue in Global (2018-2023)
7.8.5 Humanetics Key News & Latest Developments
7.9 Mission Pharmacal
7.9.1 Mission Pharmacal Company Summary
7.9.2 Mission Pharmacal Business Overview
7.9.3 Mission Pharmacal Radiation Emergency Medications Major Product Offerings
7.9.4 Mission Pharmacal Radiation Emergency Medications Sales and Revenue in Global (2018-2023)
7.9.5 Mission Pharmacal Key News & Latest Developments
7.10 Partner Therapeutics
7.10.1 Partner Therapeutics Company Summary
7.10.2 Partner Therapeutics Business Overview
7.10.3 Partner Therapeutics Radiation Emergency Medications Major Product Offerings
7.10.4 Partner Therapeutics Radiation Emergency Medications Sales and Revenue in Global (2018-2023)
7.10.5 Partner Therapeutics Key News & Latest Developments
7.11 Myelo Therapeutics
7.11.1 Myelo Therapeutics Company Summary
7.11.2 Myelo Therapeutics Business Overview
7.11.3 Myelo Therapeutics Radiation Emergency Medications Major Product Offerings
7.11.4 Myelo Therapeutics Radiation Emergency Medications Sales and Revenue in Global (2018-2023)
7.11.5 Myelo Therapeutics Key News & Latest Developments
7.12 Pluri
7.12.1 Pluri Company Summary
7.12.2 Pluri Business Overview
7.12.3 Pluri Radiation Emergency Medications Major Product Offerings
7.12.4 Pluri Radiation Emergency Medications Sales and Revenue in Global (2018-2023)
7.12.5 Pluri Key News & Latest Developments
8 Global Radiation Emergency Medications Production Capacity, Analysis
8.1 Global Radiation Emergency Medications Production Capacity, 2018-2029
8.2 Radiation Emergency Medications Production Capacity of Key Manufacturers in Global Market
8.3 Global Radiation Emergency Medications Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Radiation Emergency Medications Supply Chain Analysis
10.1 Radiation Emergency Medications Industry Value Chain
10.2 Radiation Emergency Medications Upstream Market
10.3 Radiation Emergency Medications Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Radiation Emergency Medications Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
